Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
372.10Today’s High
381.5052W low
313.0052W High
401.00Open Price
372.10Prev. Close
354.2500Volume
309563.00Value
117123161.05Fundamentals
Market Cap
5272.20
Price to Earnings
109.50
Price to Book Value
6.10
Dividend Yield
0.00
PE to Growth
1.70
Op Revenue TTM
1912.12
Net Profit TTM
48.14
Cash From Operating Activity
284.58
Return on Equity %
5.82
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
64.3
Week
64.4
Month
76.8
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
377.32
PIVOT
First Resistance
382.53
Second Resistance
386.72
Third Resistance
391.93
First Support
373.13
Second Support
367.92
Third Support
363.73
Relative Strength Index
54.39
Money Flow Index
25.21
MACD
2.73
MACD Signal
3.86
Average True Range
10.74
Average Directional Index
15.84
Rate of Change (21)
8.22
Rate of Change (125)
2.12
Commodity Channel Index
-13.8
Williams %R
-67.8
BETA
1 Month
0.64
3 Month
0.47
1 Year
0.48
3 Year
0.25
PRICE CHANGE ANALYSIS
↓ -0.43%
1 Week
Low
High
370
383.9
↑ 8.22%
1 Month
Low
High
348.95
395.95
↑ 2.71%
3 Months
Low
High
330.65
395.95
↑ 2.23%
6 Months
Low
High
314
401
↑ 18.09%
1 Year
Low
High
313
401
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 284.50 | 272.73 | 284.88 | 274.06 | 262.23 | 254.78 | 254.34 | 245.04 | 222.44 | 217.48 | 217.20 | |
| Operating Expenses Qtr | 225.53 | 220.48 | 232.34 | 224.69 | 218.69 | 203.06 | 206.35 | 197.21 | 179.76 | 175.20 | 178.27 | |
| Operating Profit Qtr | 54.85 | 46.73 | 50.41 | 47.54 | 39.98 | 49.62 | 46.72 | 45.96 | 40.43 | 40.31 | 37.39 | |
| EBIDT Qtr Cr | 42.87 | 52.25 | 52.54 | 49.37 | 40.54 | 51.72 | 47.99 | 47.83 | 15.68 | -3.23 | 164.35 | |
| Depreciation Qtr | 25.19 | 24.09 | 23.28 | 21.64 | 23.06 | 21.81 | 22.40 | 21.70 | 22.19 | 23.90 | 21.30 | |
| Net Profit Qtr | -1.76 | 8.33 | 13.70 | 13.69 | 4.18 | 14.16 | 11.00 | 10.85 | -17.92 | -39.13 | 93.90 | |
| Basic EPS Qtr | -0.13 | 0.60 | 0.98 | 0.98 | 0.30 | 1.02 | 0.79 | 0.78 | -1.29 | -3.03 | 7.49 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1116.17 | 1016.39 | 862.25 | 632.88 | 700.44 | |
| Operating Expenses Annual Cr | 903.04 | 825.31 | 702.96 | 535.40 | 572.61 | |
| Operating Profit Annual | 199.53 | 180.26 | 149.00 | 75.63 | 116.97 | |
| Operating Profit Margin Annual % | 17.88 | 17.74 | 17.28 | 11.95 | 16.70 | |
| Total Expenses Annual Cr | 1045.21 | 955.77 | 834.12 | 684.84 | 735.01 | |
| EBIDT Annual Cr | 213.13 | 191.08 | 159.28 | 97.48 | 127.83 | |
| EBIDT Annual margin % | 19.09 | 18.80 | 18.47 | 15.40 | 18.25 | |
| Depreciation | 94.20 | 88.97 | 88.36 | 86.58 | 79.41 | |
| PAT Before ExtraOrdinary Items Annual Cr | 33.96 | 40.19 | 38.25 | -191.55 | -53.30 | |
| Net Profit Annual | 33.96 | 40.19 | 38.25 | -191.55 | -53.30 | |
| Basic EPS Annual | 2.44 | 2.89 | 2.95 | -16.85 | -6.02 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1188.59 | 1145.12 | 1097.69 | 923.78 | 614.51 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 625.87 | 363.79 | 330.84 | 400.80 | 677.77 | |
| Total Current Liabilities Annual Cr | 373.43 | 220.80 | 215.08 | 249.93 | 476.64 | |
| Total Capital Plus Liabilities Annual Cr | 2187.89 | 1729.71 | 1643.62 | 1574.51 | 1768.92 | |
| Fixed Assets Annual | 974.56 | 796.85 | 778.66 | 772.77 | 957.94 | |
| Total Non Current Assets Annual | 1674.82 | 1357.19 | 1287.46 | 1246.52 | 1528.34 | |
| Total Current Assets Annual | 513.07 | 372.52 | 356.16 | 327.99 | 240.58 | |
| Total Assets Annual | 2187.89 | 1729.71 | 1643.62 | 1574.51 | 1768.92 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 188.09 | 247.15 | 359.74 | 312.11 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 194.73 | 130.40 | 124.39 | 70.89 | 86.34 | |
| Cash from Investing Activity Annual | -249.22 | -137.70 | 48.65 | -245.62 | -116.00 | |
| Cash from Financing Annual Activity | 105.36 | -41.71 | -41.04 | 235.92 | -2.76 | |
| Net Cash Flow Annual | - | -49.02 | 132.00 | 61.19 | -32.41 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 85.33 | 82.31 | 78.96 | 73.69 | 69.29 | |
| ROE Annual % | 2.85 | 3.50 | 3.48 | -20.73 | -8.67 | |
| ROCE Annual % | 6.55 | 6.76 | 4.96 | 0.82 | 3.74 | |
| Total Debt to Total Equity Annual | 0.33 | 0.11 | 0.10 | 0.23 | 0.68 | |
| EBDIT Annual Margin % | 19.33 | 19.00 | 18.69 | 15.95 | 18.53 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 499.68 | 475.94 | 490.34 | 463.10 | 446.36 | 428.33 | 421.97 | 410.96 | 367.64 | 360.98 | 355.26 | |
| Operating Expenses Qtr | 402.60 | 391.25 | 402.31 | 386.37 | 365.39 | 349.17 | 345.31 | 335.89 | 301.48 | 296.20 | 290.22 | |
| Operating Profit Qtr | 92.03 | 78.62 | 84.63 | 74.31 | 76.32 | 75.51 | 74.69 | 72.16 | 63.15 | 61.86 | 61.74 | |
| EBIDT Qtr Cr | 100.98 | 84.69 | 88.03 | 76.73 | 80.97 | 79.16 | 76.66 | 75.07 | 66.16 | 19.27 | 205.16 | |
| Depreciation Qtr | 45.98 | 44.16 | 43.21 | 41.01 | 42.20 | 40.77 | 40.83 | 39.67 | 41.10 | 41.38 | 38.02 | |
| Net Profit Qtr | 21.26 | 5.70 | 13.57 | 7.61 | 8.37 | 7.54 | 7.38 | 6.05 | 5.99 | -45.78 | 103.09 | |
| Basic EPS Qtr | 1.53 | 0.41 | 0.98 | 0.55 | 0.60 | 0.54 | 0.53 | 0.44 | 0.43 | -3.55 | 8.22 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1929.06 | 1707.63 | 1410.45 | 1030.39 | 1102.61 | |
| Operating Expenses Annual Cr | 1582.53 | 1395.76 | 1159.81 | 886.86 | 923.46 | |
| Operating Profit Annual | 329.59 | 295.66 | 237.97 | 126.58 | 172.18 | |
| Operating Profit Margin Annual % | 17.09 | 17.31 | 16.87 | 12.28 | 15.62 | |
| Total Expenses Annual Cr | 1865.63 | 1662.73 | 1415.86 | 1165.24 | 1209.55 | |
| EBIDT Annual Cr | 346.53 | 311.87 | 250.64 | 143.53 | 179.15 | |
| EBIDT Annual margin % | 17.96 | 18.26 | 17.77 | 13.93 | 16.25 | |
| Depreciation | 174.36 | 163.47 | 158.28 | 159.22 | 148.44 | |
| PAT Before ExtraOrdinary Items Annual Cr | 40.93 | 17.65 | 40.35 | -220.74 | -113.13 | |
| Net Profit Annual | 48.14 | 29.35 | 53.73 | -193.46 | -106.69 | |
| Basic EPS Annual | 3.46 | 2.10 | 3.97 | -17.02 | -12.05 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 825.78 | 860.52 | 870.29 | 697.18 | 381.25 | |
| Minority Interest Liability Annual Cr | 39.34 | 8.89 | 13.43 | 16.82 | 38.51 | |
| Total Non Current Liabilities Annual Cr | 1098.68 | 876.28 | 866.07 | 856.37 | 1257.65 | |
| Total Current Liabilities Annual Cr | 743.70 | 570.32 | 469.74 | 465.25 | 575.75 | |
| Total Capital Plus Liabilities Annual Cr | 2707.50 | 2316.02 | 2219.52 | 2035.61 | 2253.17 | |
| Fixed Assets Annual | 1618.40 | 1389.95 | 1387.59 | 1316.05 | 1582.83 | |
| Total Non Current Assets Annual | 2027.65 | 1735.68 | 1717.19 | 1600.65 | 1949.39 | |
| Total Current Assets Annual | 679.85 | 580.34 | 502.34 | 434.96 | 303.79 | |
| Total Assets Annual | 2707.50 | 2316.02 | 2219.52 | 2035.61 | 2253.17 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 137.90 | 87.24 | 108.40 | 105.13 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 284.58 | 251.59 | 220.12 | 120.52 | 130.14 | |
| Cash from Investing Activity Annual | -225.73 | -133.03 | 124.59 | -171.10 | -101.38 | |
| Cash from Financing Annual Activity | -64.02 | -140.07 | -154.88 | 112.24 | -58.42 | |
| Net Cash Flow Annual | - | -21.51 | 189.82 | 61.66 | -29.67 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 62.11 | 62.49 | 63.57 | 56.96 | 47.33 | |
| ROE Annual % | 5.82 | 3.41 | 6.17 | -27.74 | -27.98 | |
| ROCE Annual % | 8.76 | 8.50 | 5.27 | -0.99 | 1.83 | |
| Total Debt to Total Equity Annual | 0.81 | 0.46 | 0.47 | 0.59 | 1.63 | |
| EBDIT Annual Margin % | 18.12 | 18.43 | 17.93 | 14.16 | 16.35 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ICICI PRUDENTIAL EXPORTS AND SERVICES FUND | 1.23 | 74550625 | - | - |
| INTERNATIONAL FINANCE CORPORATION | 3.13 | 74550631 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| AJAIKUMAR B S | 10.41 | 74550614 | 21.15 | 0 |
| ACESO COMPANY PTE. LTD. | 60.4 | 74550620 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| TATA INDIA PHARMA & HEALTHCARE FUND | 3.37 | 74550623 |
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHA | 1.66 | 74550624 |
| ICICI PRUDENTIAL EXPORTS AND SERVICES FUND | 1.23 | 74550625 |
| INTERNATIONAL FINANCE CORPORATION | 3.13 | 74550631 |
| WELLINGTON TRUST COMPANY, NATIONAL ASSOCIATION MUL | 1.47 | 74550632 |
| CLARUS CAPITAL I | 1.18 | 74550628 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| ZAFAR AHMADULLAH | 1.55 | 74550639 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 29, 2024 | Audited Results & ESOP | - |
| Feb 08, 2024 | Quarterly Results | - |
| Nov 09, 2023 | Quarterly Results | - |
| Aug 10, 2023 | Quarterly Results & ESOP | - |
| May 25, 2023 | Audited Results | - |
| Feb 09, 2023 | Quarterly Results | - |
| Nov 10, 2022 | Quarterly Results | - |
| Aug 10, 2022 | Quarterly Results | - |
| May 26, 2022 | Audited Results | - |
| Feb 10, 2022 | Quarterly Results | - |
| Nov 11, 2021 | Quarterly Results | - |
| Aug 12, 2021 | Quarterly Results | - |
| Jun 17, 2021 | Audited Results | - |
| Feb 11, 2021 | Quarterly Results | - |
| Nov 12, 2020 | Quarterly Results | - |
| Aug 20, 2020 | Quarterly Results | - |
| Jul 28, 2020 | Audited Results | - |
| Jun 30, 2020 | Audited Results | - |
| May 07, 2020 | Preferential Issue of shares | Inter alia, to consider, amongst other agenda items, a proposal for raising capital by issue of equity shares/warrants/any other equity linked securities, through preferential basis. |
| Feb 12, 2020 | Quarterly Results | - |
| Nov 07, 2019 | Quarterly Results | - |
| Aug 08, 2019 | Quarterly Results & ESOP | Inter alia, issue and allot Equity Shares of the Company to eligible employees under ESOP scheme, up on exercise of vested stock options. |
| May 23, 2019 | Audited Results | - |
| Feb 07, 2019 | Quarterly Results | - |
| Nov 09, 2018 | Quarterly Results & ESOP | - |
| Aug 09, 2018 | Quarterly Results | - |
| May 22, 2018 | Audited Results | - |
| Feb 08, 2018 | Quarterly Results & Preferential issue | - |
| Nov 22, 2017 | Others | To consider a proposal for issuance of Equity Shares of the Company on Preferential basis. |
| Nov 07, 2017 | Quarterly Results & Preferential issue | - |
| Aug 11, 2017 | Quarterly Results | - |
| May 24, 2017 | Audited Results | - |
| Feb 08, 2017 | Quarterly Results & Others | Approve issue and allot equity shares of the Company under Employee Stock Option Scheme of the Company. |
| Nov 10, 2016 | Quarterly Results | - |
| Aug 12, 2016 | Quarterly Results | - |
| May 26, 2016 | Audited Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
02 Jul 2024
Healthcare Global Board Approves Acquisition Of Vizag Hospital
The company will first acquire 51% equity shares of Vizag Hospital from the selling shareholders.
02 Jul 2024
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Acquisition
Intimation regarding acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited by HealthCare Global Enterprises Limited from the selling shareholders.
29 Jun 2024
HealthCare Global Enterprises acquires Andhra-based MGCHRI for Rs 414 cr
This move positions HCG as a leader in a highly attractive micro-market, benefiting from a high-quality primary catchment area and substantial secondary catchment from neighboring states
29 Jun 2024
HealthCare Global Enterprises Ltd - 539787 - Closure of Trading Window
Intimation of closure of trading window for the quarter ending June 30, 2024
28 Jun 2024
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on the acquisition of Vizag Hospital and Cancer Research Centre Private Limited ("Vizag Hospital" or Mahatma Gandhi Cancer Hospital and Research Institute".
28 Jun 2024
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation on the acquisition of Vizag Hospital and Cancer Research Centre Private Limited.
28 Jun 2024
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Intimation regarding the execution of Share Purchase Agreement for the acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited by the Company and execution of Shareholders Agreement in this regard.
28 Jun 2024
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Acquisition
Intimation regarding the execution of Share Purchase Agreement for the acquisition of shares of Vizag Hospital and Cancer Care Research Centre Private Limited by the Company and execution of Shareholders agreement in this regard.
26 Jun 2024
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of shares under the Employee Stock Option Scheme, 2014 of HealthCare Global Enterprises Limited
05 Jun 2024
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings call held with Analysts / Investors on May 30, 2024
